Unknown

Dataset Information

0

High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial.


ABSTRACT: BACKGROUND:High-flow nasal cannula (HFNC) oxygen therapy is being increasingly used to prevent post-extubation hypoxemic respiratory failure and reintubation. However, evidence to support the use of HFNC in chronic obstructive pulmonary disease (COPD) patients with hypercapnic respiratory failure after extubation is limited. This study was conducted to test if HFNC is non-inferior to non-invasive ventilation (NIV) in preventing post-extubation treatment failure in COPD patients previously intubated for hypercapnic respiratory failure. METHODS:COPD patients with hypercapnic respiratory failure who were already receiving invasive ventilation were randomized to HFNC or NIV at extubation at two large tertiary academic teaching hospitals. The primary endpoint was treatment failure, defined as either resumption of invasive ventilation or switching to the other study treatment modality (NIV for patients in the NFNC group or vice versa). RESULTS:Ninety-six patients were randomly assigned to the HFNC group or NIV group. After secondary exclusion, 44 patients in the HFNC group and 42 patients in the NIV group were included in the analysis. The treatment failure rate in the HFNC group was 22.7% and 28.6% in the NIV group-risk difference of -?5.8% (95% CI, -?23.8-12.4%, p?=?0.535), which was significantly lower than the non-inferior margin of 9%. Analysis of the causes of treatment failure showed that treatment intolerance in the HFNC group was significantly lower than that in the NIV group, with a risk difference of -?50.0% (95% CI, -?74.6 to -?12.9%, p?=?0.015). One hour after extubation, the mean respiratory rates of both groups were faster than their baseline levels before extubation (p?

SUBMITTER: Tan D 

PROVIDER: S-EPMC7407427 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial.

Tan Dingyu D   Walline Joseph Harold JH   Ling Bingyu B   Xu Yan Y   Sun Jiayan J   Wang Bingxia B   Shan Xueqin X   Wang Yunyun Y   Cao Peng P   Zhu Qingcheng Q   Geng Ping P   Xu Jun J  

Critical care (London, England) 20200806 1


<h4>Background</h4>High-flow nasal cannula (HFNC) oxygen therapy is being increasingly used to prevent post-extubation hypoxemic respiratory failure and reintubation. However, evidence to support the use of HFNC in chronic obstructive pulmonary disease (COPD) patients with hypercapnic respiratory failure after extubation is limited. This study was conducted to test if HFNC is non-inferior to non-invasive ventilation (NIV) in preventing post-extubation treatment failure in COPD patients previousl  ...[more]

Similar Datasets

| S-EPMC6129104 | biostudies-literature
| S-EPMC7459687 | biostudies-literature
| S-EPMC7871306 | biostudies-literature
| S-EPMC5337350 | biostudies-literature
| S-EPMC6525416 | biostudies-literature
| S-EPMC7354657 | biostudies-literature
| S-EPMC4393594 | biostudies-other
| S-EPMC6091018 | biostudies-literature
| S-EPMC4300050 | biostudies-literature
| S-EPMC8439370 | biostudies-literature